BUSINESS● LOW1h ago · Oct 23, 2026, 8:27 PM
Phathom falls as FDA sued over refusal to accept ANDA for generic Voquezna
Seeking Alpha Tech · north america
Phathom's stock has fallen due to a lawsuit against the FDA for its refusal to accept an Abbreviated New Drug Application (ANDA) for a generic version of Voquezna. This indicates a significant regulatory and legal challenge affecting the pharmaceutical company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS21m agoBP, Louisiana reach deal to accelerate Deepwater Horizon paymentsSeeking Alpha TechBUSINESS25m agoElme Communities faces NYSE delisting; OTC trading to begin October 26; shares crashSeeking Alpha Tech